JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A4303 GSK3787

Summary: PPARβ/δ antagonist,novel and irreversible

insoluble in H2O; ≥15.8 mg/mL
A4374 PF-3845
1 Citation

Target: FAAH

Summary: FAAH ihibitor,highly potent and selective

≥55.6 mg/mL
A1920 Z-DEVD-FMK
12 Citation

Target: Caspases

Summary: Caspase-3 inhibitor

insoluble in H2O; insoluble in EtOH; ≥60 mg/mL
A1921 Z-DQMD-FMK
3 Citation

Target: Caspases

Summary: Caspase-3 inhibitor,cell-permeable

≥29.2 mg/mL
A1923 Z-VEID-FMK
2 Citation

Target: Caspases

Summary: Caspase-6 inhibitor

insoluble in H2O; ≥113.4 mg/mL
A1933 Carfilzomib (PR-171)
10 Citation

Target: Proteasome

Summary: Proteasome inhibitor, epoxomicin analog

≥35.99 mg/mL
A8162 E-64-c

Target: cysteine protease

Summary: Inhibitor of cysteine proteinases

≥31.4 mg/mL
A3420 FMK

Target: Ribosomal s6 kinases (RSK)

Summary: RSK inhibitor

insoluble in H2O; ≥17.1 mg/mL
A3708 Pentostatin
1 Citation

Target: Adenosine Deaminases

Summary: Irreversible adenosine deaminase inhibitor

≥26.8 mg/mL
A4509 PX 12

Target: Trx

Summary: Trx-1 inhibitor

insoluble in H2O; ≥8.75 mg/mL